These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 26843222

  • 1. Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis.
    Kulkarni P, Cushman T, Donthireddy V, Rao S.
    BMJ Case Rep; 2016 Feb 03; 2016():. PubMed ID: 26843222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
    Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C.
    Clin Drug Investig; 2013 Feb 03; 33(2):117-22. PubMed ID: 23184667
    [Abstract] [Full Text] [Related]

  • 5. Intravenous zoledronic acid for the treatment of osteoporosis.
    Lewiecki EM.
    Curr Osteoporos Rep; 2008 Mar 03; 6(1):17-23. PubMed ID: 18430396
    [Abstract] [Full Text] [Related]

  • 6. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
    Lee CY, Suzuki JB.
    Implant Dent; 2015 Apr 03; 24(2):227-31. PubMed ID: 25734948
    [Abstract] [Full Text] [Related]

  • 7. [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
    Dalle Carbonare L, Bertoldo F, Lo Cascio V.
    Reumatismo; 2009 Apr 03; 61(1):54-64. PubMed ID: 19370189
    [Abstract] [Full Text] [Related]

  • 8. First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy.
    Couture G, Delzor F, Bagheri H, Micallef J, Ruyssen-Witrand A, Laroche M.
    Joint Bone Spine; 2017 Mar 03; 84(2):213-215. PubMed ID: 27939801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Zoledronic acid: a review of its use in the treatment of osteoporosis.
    Deeks ED, Perry CM.
    Drugs Aging; 2008 Mar 03; 25(11):963-86. PubMed ID: 18947264
    [Abstract] [Full Text] [Related]

  • 11. [Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)].
    Ringe JD, Nitschmann S.
    Internist (Berl); 2008 Apr 03; 49(4):502-4. PubMed ID: 18305914
    [No Abstract] [Full Text] [Related]

  • 12. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug 03; 17(96):143. PubMed ID: 19480098
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB.
    Ann Pharmacother; 2008 Jul 03; 42(7):1085-9. PubMed ID: 18505912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.
    Taggart H, Cheng J, Archbold P.
    Osteoporos Int; 2010 Sep 03; 21(9):1621-2. PubMed ID: 19813042
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Zoledronic acid-induced severe lymphopenia.
    Karpuz S.
    Osteoporos Int; 2023 Sep 03; 34(9):1653-1655. PubMed ID: 37322374
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.